You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 21 - 30 of 4327 results
  1. SBIR Phase II: Power-Optimized Beamforming Front-End Technology for High-Capacity Millimeter-Wave Wireless Communications

    SBC: SKYGIG LLC            Topic: W

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to develop a platform technology as an enabler of a wide range of high-throughput wireless communications for the next generation of broadband multigigabit connectivity. The millimeter-wave (mmWave) technology solves some of the key underlying challenges of mmWave radios and networks and i ...

    SBIR Phase II 2023 National Science Foundation
  2. SBIR Phase II:AI for Enhanced Processing of Digital Conversations

    SBC: Initium AI Inc.            Topic: AI

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project lies in its potential to positively impact the sales process by enabling easier, faster, and better access to previous sales conversations and improving sales management oversight. These improvements, in turn, will lead to increased sales efficiency and customer acquisition and retention, and ...

    SBIR Phase II 2023 National Science Foundation
  3. STTR Phase I:A Novel Prescription Process that Customizes Prosthetic Feet for Individual Patients

    SBC: LITTLE ROOM INNOVATIONS LLC            Topic: MD

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is a novel process for providing customized prosthetic feet. Current prescription methods match patients with prosthetic feet designs based on the patient’s weight and level of physical activity. However, this method often neglects patient variabilities in terms of posture and walking gait a ...

    STTR Phase I 2023 National Science Foundation
  4. STTR Phase I:A novel wall-mounted gait assist system to reduce the risk of injuries on stairs and level surfaces

    SBC: 2INNOVATE LLC            Topic: MD

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is a novel mechanical system which improves the safety of the elderly and disabled while walking on level surfaces and stairs. The novel, wall-mounted system will reduce the risks of injury by mechanically supporting individuals during ambulation, rehabilitation, and eventual in-home gait assi ...

    STTR Phase I 2023 National Science Foundation
  5. Tangler Trifecta, Advanced Mating Disruption that Allows for Time and Labor Savings

    SBC: RIDGE QUEST INC.            Topic: 813

    Title: Tangler Trifecta Advanced Mating Disruption that Allows for Time and LaborSavings.Principle Director: Chandra Maleckas-BunkerNON-TECHNICAL SUMMARY: Many factors acting together including concerns about worker safetyfood safety pesticide resistance and new regulations governing pesticides have heightened growerawareness to reduce insecticide inputs and increase reliance on biopesticides. For ...

    SBIR Phase II 2023 Department of Agriculture
  6. Towards a scalable continuous flow plasma water treatment architecture for PFAS destruction

    SBC: FOURTH STATE LLC            Topic: 84

    Project SummaryPer and Poly fluorinated alkyl substances whose origins date back to the 1940s are a class ofcompounds possessing high thermal and chemical stability. The compounds have been used in a range ofconsumer products owing to these robust properties. Their unusual stability and thus long half-life have ledto the proliferation of these compounds in the environment. It is now well establish ...

    STTR Phase I 2023 Department of Agriculture
  7. Development of a novel sensor for the real-time measurement of mitral coaptation force

    SBC: MitralPint Inc.            Topic: NHLBI

    Project Summary The proposed project will develop a breakthrough endovascular sensor technology to allow for real-time quantification of the mitral coaptation force (MCF) of the mitral valve during both open and percutaneous mitral valve repair (MVR). Mitral regurgitation (MR) is the most common heart valve disorder in the U.S. population, with over 2 million individuals affected. Current methods ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. A novel platform for synthetic generation and statistical obfuscation of tabular clinical data, simulated images, and machine-generated text

    SBC: GRAYRAIN, LLC            Topic: NCATS

    PROJECT SUMMARY Data is a critical and highly valuable commodity, driving meaningful change in our society, especially when it pertains to patient care and biomedical research. Currently, institutions pay inordinate sums to increase, regain, and complement their data panels. As an extra burden, data legislation and privacy protection regulations introduce barriers to forming effective partnerships ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Structure-based computational engineering of saCas9 PAM requirement

    SBC: ATGC Inc.            Topic: 400

    ABSTRACT SaCas9 is a major gene editing nuclease that is preferred for in vivo applications thanks to its relatively smaller size compared to that of spCas9. One limiting factor for the use of saCas9 is its strict PAM requirement of NNGRRT. In addition, there are limited efforts to reduce saCas9’s off-target editing rates. In Aim 1, we propose a computational approach to relax saCas9’s PAM req ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Development of the HC2099 series of MmpL3 inhibitors to treat tuberculosis

    SBC: TARN BIOSCIENCES, INC.            Topic: NIAID

    Tarn Biosciences, Inc. is a start-up pharmaceutical company headquartered in East Lansing, Michigan. The company is developing new therapies for tuberculosis (TB). The goal of this STTR is to develop the MmpL3 inhibitor, HC2099, as a new treatment for drug susceptible and multidrug-resistant TB (MDR-TB). In 2019, 10 million people worldwide fell ill to TB with ~ 1.4 million lives lost. Standard-of ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government